Free Trial

Flora Growth (FLGC) Competitors

Flora Growth logo
$0.60 +0.01 (+2.21%)
Closing price 03:58 PM Eastern
Extended Trading
$0.57 -0.03 (-4.17%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FLGC vs. AADI, APLT, BLUE, COEP, DYAI, STTK, ELYM, ATNM, HOWL, and LVTX

Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Aadi Bioscience (AADI), Applied Therapeutics (APLT), bluebird bio (BLUE), Coeptis Therapeutics (COEP), Dyadic International (DYAI), Shattuck Labs (STTK), Eliem Therapeutics (ELYM), Actinium Pharmaceuticals (ATNM), Werewolf Therapeutics (HOWL), and LAVA Therapeutics (LVTX). These companies are all part of the "pharmaceutical products" industry.

Flora Growth vs.

Aadi Bioscience (NASDAQ:AADI) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Flora Growth has higher revenue and earnings than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aadi Bioscience$25.07M1.46-$65.76M-$2.35-0.63
Flora Growth$59.51M0.20-$57.04M-$1.32-0.45

Flora Growth received 4 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 60.00% of users gave Flora Growth an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote.

CompanyUnderperformOutperform
Aadi BioscienceOutperform Votes
11
39.29%
Underperform Votes
17
60.71%
Flora GrowthOutperform Votes
15
60.00%
Underperform Votes
10
40.00%

52.1% of Aadi Bioscience shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 37.3% of Aadi Bioscience shares are held by insiders. Comparatively, 13.0% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Flora Growth has a net margin of -30.99% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Flora Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Aadi Bioscience-246.06% -71.87% -57.28%
Flora Growth -30.99%-268.17%-57.51%

In the previous week, Flora Growth had 2 more articles in the media than Aadi Bioscience. MarketBeat recorded 2 mentions for Flora Growth and 0 mentions for Aadi Bioscience. Flora Growth's average media sentiment score of 1.45 beat Aadi Bioscience's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media.

Company Overall Sentiment
Aadi Bioscience Neutral
Flora Growth Positive

Aadi Bioscience presently has a consensus target price of $1.67, indicating a potential upside of 12.61%. Flora Growth has a consensus target price of $5.00, indicating a potential upside of 733.33%. Given Flora Growth's stronger consensus rating and higher probable upside, analysts plainly believe Flora Growth is more favorable than Aadi Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aadi Bioscience
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Flora Growth
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Aadi Bioscience has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500.

Summary

Flora Growth beats Aadi Bioscience on 13 of the 18 factors compared between the two stocks.

Get Flora Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGC vs. The Competition

MetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$11.66M$6.69B$5.47B$7.92B
Dividend YieldN/A3.05%5.11%4.22%
P/E Ratio-0.457.3222.5118.54
Price / Sales0.20241.49397.62103.35
Price / CashN/A65.8538.1834.62
Price / Book0.776.486.734.25
Net Income-$57.04M$143.41M$3.22B$248.18M
7 Day Performance3.45%2.30%1.58%1.25%
1 Month Performance0.02%7.14%4.05%3.76%
1 Year Performance-64.91%-2.61%15.75%5.28%

Flora Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FLGC
Flora Growth
3.3206 of 5 stars
$0.60
+2.2%
$5.00
+733.3%
-65.3%$11.66M$59.51M-0.45280Short Interest ↓
Positive News
Gap Up
AADI
Aadi Bioscience
N/A$1.57
+1.9%
$1.67
+6.2%
-22.9%$38.77M$25.07M-0.6940Upcoming Earnings
APLT
Applied Therapeutics
4.0816 of 5 stars
$0.33
-0.1%
$6.10
+1,734.0%
-90.7%$38.70M$455,000.00-0.2130Upcoming Earnings
News Coverage
Positive News
BLUE
bluebird bio
3.0043 of 5 stars
$3.90
-5.8%
$44.60
+1,043.6%
-77.0%$38.18M$83.81M-0.10520Upcoming Earnings
Analyst Forecast
COEP
Coeptis Therapeutics
1.1128 of 5 stars
$11.19
+11.9%
N/A+34.9%$37.65MN/A-1.932Short Interest ↓
Gap Up
DYAI
Dyadic International
2.8942 of 5 stars
$1.25
+1.6%
$6.00
+380.0%
-14.7%$37.61M$3.50M-5.437Short Interest ↓
News Coverage
STTK
Shattuck Labs
2.5582 of 5 stars
$0.79
+1.5%
$7.50
+855.3%
-90.6%$37.61M$5.72M-0.51100Earnings Report
News Coverage
Positive News
ELYM
Eliem Therapeutics
N/A$1.26
flat
N/A-82.1%$37.49MN/A-2.389Gap Down
ATNM
Actinium Pharmaceuticals
1.4132 of 5 stars
$1.20
-0.8%
$7.40
+516.7%
-80.3%$37.44M$81,000.00-0.8630Analyst Forecast
Analyst Revision
HOWL
Werewolf Therapeutics
2.2545 of 5 stars
$0.83
-9.7%
$9.00
+984.6%
-85.5%$37.20M$1.89M-0.5440Upcoming Earnings
News Coverage
LVTX
LAVA Therapeutics
2.3476 of 5 stars
$1.40
+6.6%
$3.17
+126.7%
-56.7%$36.75M$11.98M-1.3660Short Interest ↓

Related Companies and Tools


This page (NASDAQ:FLGC) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners